ID
45883
Beskrivning
Principal Investigator: M. Benjamin Shoemaker, MD, Vanderbilt University, Nashville, TN,USA MeSH: Atrial Fibrillation https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000997 The Vanderbilt Atrial Fibrillation Ablation Registry (VAFAR) was founded in 2011. Patients with AF referred for AF ablation are prospectively enrolled. A detailed clinical history is recorded, along with imaging data (cardiac MRI or CT). Blood samples are obtained for DNA extraction at the time of ablation. Details of the ablation procedure are recorded. Patients are longitudinally followed to monitor for AF recurrence. VAFAR contributed 171 samples submitted to dbGaP for WGS: 115 were from male subjects, of which 113 were white/non-Hispanic and 2 were Hispanic; 56 were from females, of which all 56 were white/non-Hispanic.
Länk
Nyckelord
Versioner (1)
- 2023-11-13 2023-11-13 - Simon Heim
Rättsinnehavare
M. Benjamin Shoemaker, MD, Vanderbilt University, Nashville, TN,USA
Uppladdad den
13 november 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000997 NHLBI TOPMed - NHGRI CCDG: The Vanderbilt AF Ablation Registry
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, and affection status for atrial fibrillation (AF).
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes data table includes body site where sample was collected, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, and study name.
- This subject phenotype data table includes subject's sex, race, ethnicity, age at diagnosis, and the following variables collected at enrollment or closest to enrollment: atrial fibrillation status, age, height, weight, hypertension, diabetes, heart failure, myocardial infarction, valvular heart disease, LA size and LVEF by echocardiography, and EF ever less than 50%.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, and affection status for atrial fibrillation (AF).
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes data table includes body site where sample was collected, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, and study name.
- This subject phenotype data table includes subject's sex, race, ethnicity, age at diagnosis, and the following variables collected at enrollment or closest to enrollment: atrial fibrillation status, age, height, weight, hypertension, diabetes, heart failure, myocardial infarction, valvular heart disease, LA size and LVEF by echocardiography, and EF ever less than 50%.
C0680251 (UMLS CUI [1,2])
C2702800 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,3])
Inga kommentarer